Home
Cerbios

Cerbios Market Share Analysis for November 2025

Starting in 1976 with research, development and production of pharmaceutical probiotics, Cerbios also developed a probiotic feed additive product line.

Health > Biotechnology and Pharmaceuticals

Domaincerbios.ch

Year Founded1976

Employees51 - 200

Annual Revenue--

Cerbios

Cerbios (including company regionals)

cerbios.ch

See more website traffic and engagement information

Total visits to Cerbios's top domains

Understand Cerbios market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Cerbios's top domains

Analyze Cerbios engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Cerbios's top domains

See how Cerbios keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Cerbios top competitors by domain

Top similar sites in November 2025, ranked by their affinity

abiogen.itCompany NameAbiogen Pharma S.p.A.Employees201 - 500HQItaly, PisaAnnual revenue$200M - $500MTotal visits9.9KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Cerbios

These are the website technologies, by industry, used by Cerbios top domains

Widget (6)

Twemoji

Mobile (3)

Meta Viewport

Conversion & Analytics (2)

Google Analytics

Payment & Currencies (2)

Pound Sterling

More Technologies

6

See all

News & Signals from Cerbios

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCerbios launches SF68 SKINActive.Cerbios-Pharma has released SF68® SKINActive as an innovative probiotic-based treatment for skin disorders.

NewsCerbios launches SF68 Immunoblase.Cerbios-Pharma has released SF68® Immunoblase as a fully formulated immunity boosting system, with scientific evidence supporting claims for protection from respiratory viruses and enhanced vaccine efficacy.

NewsCerbios promoted Claudio Pozzoli to Chief Operation Officer on Oct 1st '19.Cerbios-Pharma SA (from now on “Cerbios”) is pleased to announce that Mr. Claudio Pozzoli has been promoted as Chief Operation Officer (COO) and Alberto Terraneo is our new R&D Director.